Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential therapy for mite folliculitis
ChiCTR-IPR-15006451Phase 4Completed
- Sponsor
- The 940 Hospital of the Joint Logistics Support Force
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ornidazole, metronidazole, betamethasone and eribulin in folliculitis (4 arms), sponsored by The 940 Hospital of the Joint Logistics Support Force. Primary endpoint: Number of cases with detectable mites. Started May 2014; status: completed.
02
Drugs
ornidazolemetronidazolebetamethasoneeribulin
03
Conditions
folliculitis
Beyond the preview
Go deeper on ChiCTR-IPR-15006451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006451.